WaystarWAY

Barclays kept its overweight rating, which is their way of saying they expect the stock to do better than the average company. They raised their target price from $25 to $27. This suggests they see a bit more value in the business after the recent numbers, though it is a small adjustment compared to the current stock price.

Source: Barclays

Deutsche Bank raised its target from $36 to $39. This follows the company's report of 18 percent revenue growth and an increase in its full-year expectations. A higher target from a major firm like this shows they are becoming more confident in the company's ability to grow its profits as it automates more healthcare payments.

Source: Deutsche Bank

UBS maintained its buy rating while lowering its target from $37 to $33. Even with the lower target, the firm still sees significant room for the stock to rise from its current level. This kind of move often happens when an analyst still likes the business but wants their target to be more realistic given where the stock is actually trading.

Source: UBS

Wells Fargo kept its overweight rating but cut its target from $36 to $33. This matches the target set by UBS on the same day. It suggests that while analysts are happy with the 18 percent growth the company just reported, they are being more cautious about how much investors are willing to pay for those earnings right now.

Source: Wells Fargo

The company appointed Alpana Wegner as its new Chief Financial Officer, effective August 1. She joins from a background in technology finance, which fits Waystar's focus on growing its software and AI capabilities.

A change in the person running the finances is always worth watching, but this looks like a planned move to bring in leadership that matches the company's next phase of growth. Since the company also raised its financial goals on the same day, the transition appears to be happening from a position of strength.

Source: PRNewsWire

Metrics we are tracking